Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences

Rheumatology

Volumn 47, Issue 6, 2008, Pages 920-923

  Ruiz irastorza, G ^a,b   Egurbide, M V ^a   Olivares, N ^a   Martinez Berriotxoa, A ^a   Aguirre, C ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Calcidiol; Calcitriol; Cholecalciferol; Damage; Hydroxychloroquine; Prognosis; Systemic lupus erythematosus

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; VITAMIN D;

ADULT; AGE DISTRIBUTION; ARTICLE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGE FACTORS; ANTIRHEUMATIC AGENTS; CALCIFEDIOL; CROSS-SECTIONAL STUDIES; FATIGUE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; VITAMIN D DEFICIENCY;

EID: 44849123210     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken121     Document Type: Article

References (27)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
2. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-73.
3. Janssen HCJP, Samson MM, Verhaar HJJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002;75:611-5.
4. Holick MF. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 1004;79:362-71.
5. Bultnik IEM, Lems WF, Kostene PJ, Dijkmans BAC, Voskuyl AE. Prevalence and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005;54:2044-50.
6. Müller K, Kriegbaum NJ, Baslund B et al. Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995;14:397-400.
7. Huisman AM, White KP, Algra A et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001;28:2535-9.
8. Kamen DL, Cooper GS, Bouali H et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114-7.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
10. Ward MM, Marx AS, Barry NN. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 2000;27:664-70.
11. Gladman DD, Goldsmith CH, Urowitz MB et al. The Systemic Lupus Erythematosus International Collaborating Clinics/American College of Rheumatology index for systemic lupus erythematosus international comparison. J Rheumatol 2000; 27:373-6.
12. Verdon F, Burnand B, Fallab Subi C-L et al. Iron supplementation for unexplained fatigue in non-anaemic women: Double blind randomised placebo controlled trial. Br Med J 2003;326:1124-7.
13. Barnes TC, Bucknall RC. Vitamin D deficiency in a patient with systemic lupus erythematosus. Rheumatology 2004;43:393-4.
14. Sharma OP. Hypercalcemia in granulomatous disorders: A clinical review. Curr Opin Pulm Med 2000;6:442-7.
15. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 2001;28:102-8.
16. Martins D, Wolf M, Pan D et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med 2007;167:1159-65.
17. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7.
18. Ruiz-Irastorza G, Egurbide MV, Pijoan JI et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 2006;15:577-83.
19. Ruiz-Irastorza G, Ugarte A, Egurbide MV et al. Antimalarials may influence the risk of malignancy in systemic lupus erythematosus. Ann Rheum Dis 2007;66:815-7.
20. Alarcon GS, McGwin G Jr, Bertoli AM et al. Effect of hydroxychloroquine in the survival of patients with systemic lupus erythematosus. Data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 2007;66:1168-72.
21. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive Actions of 1, 25-dihydroxy vitamin D3: Preferential Inhibition of Th1 Functions. J Nutr 1995;125:1704S-8S.
22. Linker-Israeli M, Elstner E, Klinenberg JR, Wallace DJ, Koeffler HP. Vitamin D3 and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol 2001;99:82-93.
23. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80:1717S-20S.
24. Harel M, Shoenfeld Y. Predicting and preventing autoimmunity, myth or reality? Ann NY Acad Sci 2006;1069:322-45.
25. Costenbader KH, Feskanich D, Benito-Garcia E, Holmas M, Karlson E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2007, Jul 31; [Epub ahead of print].
26. Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. Br Med J 2005;330:524-6.
27. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137-42.